Pfizer: Clinical Trials & Research Profile

Biopharma Industry (New York, NY) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (New York, NY)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies143 active (81 recruiting now)
Total Tracked Studies (2018 to 2026)377 (261 with California sites)
Completed vs Early-Stopped Studies161 completed / 73 stopped (19.4% stop rate)
Median Closed Enrollment241 participants
FDA Drugs@FDA Original Approvals418 all-time (34 from 2018 to 2026)
Physical Hospital Site Disclosure99.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Pfizer across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk